OCI-AML3, a NPM1 mutated cell line, demonstrated in vitro and in vivo sensitivity to dexamethasone compared to wild type cell lines and primary AML samples with NPM1 mutation were also more sensitive to dexamethasone-induced apoptosis than wild type samples (71, 110). This evidence concerns the gene NPM1 and acute myeloid leukemia.